Calcium Dobesilate Tablets & Capsules Suppliers & Bulk Manufacturers

Available Forms: Tablets & Capsules

Available Strengths: 250 mg & 500 mg

Reference Brands: Doxium®, Doxium MADAUS® (EU)

Category: Diabetes

Calcium Dobesilate Tablets & Capsules is available in Tablets & Capsules and strengths such as 250 mg & 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Calcium Dobesilate Tablets & Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Calcium Dobesilate Tablets & Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Calcium Dobesilate is primarily approved and marketed in the European Union and several other countries but is not FDA-approved in the United States. It is widely prescribed in the EU under brand names like Doxium® for the treatment of chronic venous insufficiency, diabetic retinopathy, and hemorrhoidal disease. The drug is classified as a vasoprotective agent with angioprotective and anti-inflammatory effects. Regulatory bodies in the EU consider it safe and effective when prescribed appropriately, although it is not included in U.S. pharmacotherapy due to lack of FDA approval. Physicians in the EU continue to favor it for vascular and retinal microcirculation support.